Suicide Prevention, Part 2: Evidence-Based Practices, Cost-Effectiveness, and Future Directions
Psychiatr Serv
.
2020 Dec 1;71(12):1320-1321.
doi: 10.1176/appi.ps.711205.
Authors
Matthew L Goldman
,
Lisa B Dixon
PMID:
33256525
DOI:
10.1176/appi.ps.711205
No abstract available
MeSH terms
Cost-Benefit Analysis
Evidence-Based Practice
Humans
Suicide Prevention*